Global Hyperammonemia Treatment Supply, Demand and Key Producers, 2023-2029

February 2023 | 110 pages | ID: G0EE197FB81FEN
GlobalInfoResearch

Abstracts

This report studies the global Hyperammonemia Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hyperammonemia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperammonemia Treatment that contribute to its increasing demand across many markets.

The global Hyperammonemia Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Hyperammonemia Treatment total market, 2018-2029, (USD Million)

Global Hyperammonemia Treatment total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Hyperammonemia Treatment total market, key domestic companies and share, (USD Million)

Global Hyperammonemia Treatment revenue by player and market share 2018-2023, (USD Million)

Global Hyperammonemia Treatment total market by Type, CAGR, 2018-2029, (USD Million)

Global Hyperammonemia Treatment total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Hyperammonemia Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Recordati Rare Diseases, Lucane Pharma, Acer Therapeutics, Ultragenyx Pharmaceutical, Aeglea BioTherapeutics, Arcturus Therapeutics, Orpharma and Abbott Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperammonemia Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hyperammonemia Treatment Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Hyperammonemia Treatment Market, Segmentation by Type

• Amino Acid Supplements
• Sodium Phenylbutyrate
• Glycerol Phenylbutyrate
• Sodium Benzoate
• Others

Global Hyperammonemia Treatment Market, Segmentation by Application

• Hospitals
• Clinics

Companies Profiled:

• Bausch Health
• Recordati Rare Diseases
• Lucane Pharma
• Acer Therapeutics
• Ultragenyx Pharmaceutical
• Aeglea BioTherapeutics
• Arcturus Therapeutics
• Orpharma
• Abbott Laboratories
• Selecta Biosciences

Key Questions Answered

1. How big is the global Hyperammonemia Treatment market?

2. What is the demand of the global Hyperammonemia Treatment market?

3. What is the year over year growth of the global Hyperammonemia Treatment market?

4. What is the total value of the global Hyperammonemia Treatment market?

5. Who are the major players in the global Hyperammonemia Treatment market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Hyperammonemia Treatment Introduction
1.2 World Hyperammonemia Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hyperammonemia Treatment Total Market by Region (by Headquarter Location)
  1.3.1 World Hyperammonemia Treatment Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Hyperammonemia Treatment Market Size (2018-2029)
  1.3.3 China Hyperammonemia Treatment Market Size (2018-2029)
  1.3.4 Europe Hyperammonemia Treatment Market Size (2018-2029)
  1.3.5 Japan Hyperammonemia Treatment Market Size (2018-2029)
  1.3.6 South Korea Hyperammonemia Treatment Market Size (2018-2029)
  1.3.7 ASEAN Hyperammonemia Treatment Market Size (2018-2029)
  1.3.8 India Hyperammonemia Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Hyperammonemia Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Hyperammonemia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Hyperammonemia Treatment Consumption Value (2018-2029)
2.2 World Hyperammonemia Treatment Consumption Value by Region
  2.2.1 World Hyperammonemia Treatment Consumption Value by Region (2018-2023)
  2.2.2 World Hyperammonemia Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Hyperammonemia Treatment Consumption Value (2018-2029)
2.4 China Hyperammonemia Treatment Consumption Value (2018-2029)
2.5 Europe Hyperammonemia Treatment Consumption Value (2018-2029)
2.6 Japan Hyperammonemia Treatment Consumption Value (2018-2029)
2.7 South Korea Hyperammonemia Treatment Consumption Value (2018-2029)
2.8 ASEAN Hyperammonemia Treatment Consumption Value (2018-2029)
2.9 India Hyperammonemia Treatment Consumption Value (2018-2029)

3 WORLD HYPERAMMONEMIA TREATMENT COMPANIES COMPETITIVE ANALYSIS

3.1 World Hyperammonemia Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Hyperammonemia Treatment Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Hyperammonemia Treatment in 2022
  3.2.3 Global Concentration Ratios (CR8) for Hyperammonemia Treatment in 2022
3.3 Hyperammonemia Treatment Company Evaluation Quadrant
3.4 Hyperammonemia Treatment Market: Overall Company Footprint Analysis
  3.4.1 Hyperammonemia Treatment Market: Region Footprint
  3.4.2 Hyperammonemia Treatment Market: Company Product Type Footprint
  3.4.3 Hyperammonemia Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Hyperammonemia Treatment Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Hyperammonemia Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Hyperammonemia Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hyperammonemia Treatment Consumption Value Comparison
  4.2.1 United States VS China: Hyperammonemia Treatment Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Hyperammonemia Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hyperammonemia Treatment Companies and Market Share, 2018-2023
  4.3.1 United States Based Hyperammonemia Treatment Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Hyperammonemia Treatment Revenue, (2018-2023)
4.4 China Based Companies Hyperammonemia Treatment Revenue and Market Share, 2018-2023
  4.4.1 China Based Hyperammonemia Treatment Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Hyperammonemia Treatment Revenue, (2018-2023)
4.5 Rest of World Based Hyperammonemia Treatment Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Hyperammonemia Treatment Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Hyperammonemia Treatment Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Hyperammonemia Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Amino Acid Supplements
  5.2.2 Sodium Phenylbutyrate
  5.2.3 Glycerol Phenylbutyrate
  5.2.4 Sodium Benzoate
  5.2.5 Others
5.3 Market Segment by Type
  5.3.1 World Hyperammonemia Treatment Market Size by Type (2018-2023)
  5.3.2 World Hyperammonemia Treatment Market Size by Type (2024-2029)
  5.3.3 World Hyperammonemia Treatment Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Hyperammonemia Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Clinics
6.3 Market Segment by Application
  6.3.1 World Hyperammonemia Treatment Market Size by Application (2018-2023)
  6.3.2 World Hyperammonemia Treatment Market Size by Application (2024-2029)
  6.3.3 World Hyperammonemia Treatment Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Bausch Health
  7.1.1 Bausch Health Details
  7.1.2 Bausch Health Major Business
  7.1.3 Bausch Health Hyperammonemia Treatment Product and Services
  7.1.4 Bausch Health Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Bausch Health Recent Developments/Updates
  7.1.6 Bausch Health Competitive Strengths & Weaknesses
7.2 Recordati Rare Diseases
  7.2.1 Recordati Rare Diseases Details
  7.2.2 Recordati Rare Diseases Major Business
  7.2.3 Recordati Rare Diseases Hyperammonemia Treatment Product and Services
  7.2.4 Recordati Rare Diseases Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Recordati Rare Diseases Recent Developments/Updates
  7.2.6 Recordati Rare Diseases Competitive Strengths & Weaknesses
7.3 Lucane Pharma
  7.3.1 Lucane Pharma Details
  7.3.2 Lucane Pharma Major Business
  7.3.3 Lucane Pharma Hyperammonemia Treatment Product and Services
  7.3.4 Lucane Pharma Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Lucane Pharma Recent Developments/Updates
  7.3.6 Lucane Pharma Competitive Strengths & Weaknesses
7.4 Acer Therapeutics
  7.4.1 Acer Therapeutics Details
  7.4.2 Acer Therapeutics Major Business
  7.4.3 Acer Therapeutics Hyperammonemia Treatment Product and Services
  7.4.4 Acer Therapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Acer Therapeutics Recent Developments/Updates
  7.4.6 Acer Therapeutics Competitive Strengths & Weaknesses
7.5 Ultragenyx Pharmaceutical
  7.5.1 Ultragenyx Pharmaceutical Details
  7.5.2 Ultragenyx Pharmaceutical Major Business
  7.5.3 Ultragenyx Pharmaceutical Hyperammonemia Treatment Product and Services
  7.5.4 Ultragenyx Pharmaceutical Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Ultragenyx Pharmaceutical Recent Developments/Updates
  7.5.6 Ultragenyx Pharmaceutical Competitive Strengths & Weaknesses
7.6 Aeglea BioTherapeutics
  7.6.1 Aeglea BioTherapeutics Details
  7.6.2 Aeglea BioTherapeutics Major Business
  7.6.3 Aeglea BioTherapeutics Hyperammonemia Treatment Product and Services
  7.6.4 Aeglea BioTherapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Aeglea BioTherapeutics Recent Developments/Updates
  7.6.6 Aeglea BioTherapeutics Competitive Strengths & Weaknesses
7.7 Arcturus Therapeutics
  7.7.1 Arcturus Therapeutics Details
  7.7.2 Arcturus Therapeutics Major Business
  7.7.3 Arcturus Therapeutics Hyperammonemia Treatment Product and Services
  7.7.4 Arcturus Therapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Arcturus Therapeutics Recent Developments/Updates
  7.7.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.8 Orpharma
  7.8.1 Orpharma Details
  7.8.2 Orpharma Major Business
  7.8.3 Orpharma Hyperammonemia Treatment Product and Services
  7.8.4 Orpharma Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Orpharma Recent Developments/Updates
  7.8.6 Orpharma Competitive Strengths & Weaknesses
7.9 Abbott Laboratories
  7.9.1 Abbott Laboratories Details
  7.9.2 Abbott Laboratories Major Business
  7.9.3 Abbott Laboratories Hyperammonemia Treatment Product and Services
  7.9.4 Abbott Laboratories Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Abbott Laboratories Recent Developments/Updates
  7.9.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.10 Selecta Biosciences
  7.10.1 Selecta Biosciences Details
  7.10.2 Selecta Biosciences Major Business
  7.10.3 Selecta Biosciences Hyperammonemia Treatment Product and Services
  7.10.4 Selecta Biosciences Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Selecta Biosciences Recent Developments/Updates
  7.10.6 Selecta Biosciences Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Hyperammonemia Treatment Industry Chain
8.2 Hyperammonemia Treatment Upstream Analysis
8.3 Hyperammonemia Treatment Midstream Analysis
8.4 Hyperammonemia Treatment Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Hyperammonemia Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hyperammonemia Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hyperammonemia Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hyperammonemia Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hyperammonemia Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hyperammonemia Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hyperammonemia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hyperammonemia Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hyperammonemia Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hyperammonemia Treatment Players in 2022
Table 12. World Hyperammonemia Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hyperammonemia Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Hyperammonemia Treatment Player
Table 15. Hyperammonemia Treatment Market: Company Product Type Footprint
Table 16. Hyperammonemia Treatment Market: Company Product Application Footprint
Table 17. Hyperammonemia Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Hyperammonemia Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hyperammonemia Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hyperammonemia Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hyperammonemia Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hyperammonemia Treatment Revenue Market Share (2018-2023)
Table 23. China Based Hyperammonemia Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hyperammonemia Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hyperammonemia Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hyperammonemia Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hyperammonemia Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hyperammonemia Treatment Revenue Market Share (2018-2023)
Table 29. World Hyperammonemia Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hyperammonemia Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hyperammonemia Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hyperammonemia Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hyperammonemia Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hyperammonemia Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Bausch Health Basic Information, Area Served and Competitors
Table 36. Bausch Health Major Business
Table 37. Bausch Health Hyperammonemia Treatment Product and Services
Table 38. Bausch Health Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Bausch Health Recent Developments/Updates
Table 40. Bausch Health Competitive Strengths & Weaknesses
Table 41. Recordati Rare Diseases Basic Information, Area Served and Competitors
Table 42. Recordati Rare Diseases Major Business
Table 43. Recordati Rare Diseases Hyperammonemia Treatment Product and Services
Table 44. Recordati Rare Diseases Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Recordati Rare Diseases Recent Developments/Updates
Table 46. Recordati Rare Diseases Competitive Strengths & Weaknesses
Table 47. Lucane Pharma Basic Information, Area Served and Competitors
Table 48. Lucane Pharma Major Business
Table 49. Lucane Pharma Hyperammonemia Treatment Product and Services
Table 50. Lucane Pharma Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Lucane Pharma Recent Developments/Updates
Table 52. Lucane Pharma Competitive Strengths & Weaknesses
Table 53. Acer Therapeutics Basic Information, Area Served and Competitors
Table 54. Acer Therapeutics Major Business
Table 55. Acer Therapeutics Hyperammonemia Treatment Product and Services
Table 56. Acer Therapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Acer Therapeutics Recent Developments/Updates
Table 58. Acer Therapeutics Competitive Strengths & Weaknesses
Table 59. Ultragenyx Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Ultragenyx Pharmaceutical Major Business
Table 61. Ultragenyx Pharmaceutical Hyperammonemia Treatment Product and Services
Table 62. Ultragenyx Pharmaceutical Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Ultragenyx Pharmaceutical Recent Developments/Updates
Table 64. Ultragenyx Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Aeglea BioTherapeutics Basic Information, Area Served and Competitors
Table 66. Aeglea BioTherapeutics Major Business
Table 67. Aeglea BioTherapeutics Hyperammonemia Treatment Product and Services
Table 68. Aeglea BioTherapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Aeglea BioTherapeutics Recent Developments/Updates
Table 70. Aeglea BioTherapeutics Competitive Strengths & Weaknesses
Table 71. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 72. Arcturus Therapeutics Major Business
Table 73. Arcturus Therapeutics Hyperammonemia Treatment Product and Services
Table 74. Arcturus Therapeutics Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Arcturus Therapeutics Recent Developments/Updates
Table 76. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 77. Orpharma Basic Information, Area Served and Competitors
Table 78. Orpharma Major Business
Table 79. Orpharma Hyperammonemia Treatment Product and Services
Table 80. Orpharma Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Orpharma Recent Developments/Updates
Table 82. Orpharma Competitive Strengths & Weaknesses
Table 83. Abbott Laboratories Basic Information, Area Served and Competitors
Table 84. Abbott Laboratories Major Business
Table 85. Abbott Laboratories Hyperammonemia Treatment Product and Services
Table 86. Abbott Laboratories Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Abbott Laboratories Recent Developments/Updates
Table 88. Selecta Biosciences Basic Information, Area Served and Competitors
Table 89. Selecta Biosciences Major Business
Table 90. Selecta Biosciences Hyperammonemia Treatment Product and Services
Table 91. Selecta Biosciences Hyperammonemia Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Hyperammonemia Treatment Upstream (Raw Materials)
Table 93. Hyperammonemia Treatment Typical Customers
List of Figure
Figure 1. Hyperammonemia Treatment Picture
Figure 2. World Hyperammonemia Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hyperammonemia Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hyperammonemia Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hyperammonemia Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hyperammonemia Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Hyperammonemia Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hyperammonemia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hyperammonemia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hyperammonemia Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hyperammonemia Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hyperammonemia Treatment Markets in 2022
Figure 27. United States VS China: Hyperammonemia Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hyperammonemia Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hyperammonemia Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hyperammonemia Treatment Market Size Market Share by Type in 2022
Figure 31. Amino Acid Supplements
Figure 32. Sodium Phenylbutyrate
Figure 33. Glycerol Phenylbutyrate
Figure 34. Sodium Benzoate
Figure 35. Others
Figure 36. World Hyperammonemia Treatment Market Size Market Share by Type (2018-2029)
Figure 37. World Hyperammonemia Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Hyperammonemia Treatment Market Size Market Share by Application in 2022
Figure 39. Hospitals
Figure 40. Clinics
Figure 41. Hyperammonemia Treatment Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source